Skip to content

Public FDA record

Z-0337-2022: Cardiosave Rescue IntraAortic Balloon Pump. Model Numbers: 0998-00-0800-75, 0998-UC-0800-75, 0998-00-0800

Recall record Z-0337-2022 for Datascope Corp.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0337-2022
Company in FDA record
Datascope Corp.
FDA classification date
Dec 30, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class I

Reason stated in the source

Firm is initiating a correction due to the possibility of fluid ingress. Fluid entering the device may short various electronic components thus leading to system shutdown, which could result in unsafe hemodynamic instability.

Source facts

Action
On November 15, 2021, the firm issued an Urgent Medical Device Correction letter to all affected consignees which informed them that the exterior of the Cardiosave Hybrid and Rescue IABP may be susceptible to fluid ingress at specific locations on the device. IABPs contain various electronic circuit boards. Liquid spills, such as saline, can create bridges of resistance between the circuit components; causing the circuit to not function as intended. This can impact initiation or continuation of counterpulsation therapy. Datascope/Getinge had previously issued an Urgent Medical Device Correction letter on April 26, 2018 to install a Top Protective Cover for the Cardiosave Hybrid IABP to help reduce the potential for fluid ingress. However, in some instances and depending on the volume of spill, this Top Protective Cover can overflow and fluid can enter the device in other susceptible areas. Consignees were requested to immediately examine inventory to determine if there is affected product on hand and that a correction should be available in 2022. Consignees were advised that in the meantime, continue to follow the IFU and adhere to the instructions when using the Cardiosave Hybrid and/or Rescue IABP In the unlikely event that a sudden interruption of therapy occurs, transfer the patient to an alternative IABP. If an alternative IABP is unavailable; manually inflate the IAB with air or helium and immediately aspirate, repeat every 5 minutes until either an alternate IABP is available or alternatively, the intra-aortic balloon catheter should be removed from the patient. The Intra-Aortic Balloon (IAB) Catheter Instructions for Use reinforces that the IAB catheter should not remain inactive (i.e. not inflating and deflating) for more than 30 minutes because of the potential for thrombus formation. Consignees were requested to forward this information to all current and potential affected. Distributors were also requested to forward the letter to customer atte
Initiated
2021-11-15
Root cause
Device Design
Distribution
Worldwide distribution - US Nationwide.
Recall number
Z-0337-2022
Recall status
Open, Classified
CDRH record ID
190172
FDA classified
2021-12-30
Recall event number
88983

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗